top of page
Endocrine System Digital Registration Assessment Study Guide (2023-2024 Edition)

Endocrine System Digital Registration Assessment Study Guide (2023-2024 Edition)

The 58-Page Endocrine System Digital Registration Assessment Study Guide (2023-2024 Edition) includes: 

 

  • Diabetes insipidus
  • Desmopressin
  • Vasopressin
  • Corticosteroid replacement therapy
  • Glucocorticoid therapy
  • Equivalent doses of corticosteroids
  • Glucocorticoids
  • Mineralocorticoids
  • Managing corticosteroid side effects
  • Systemic side effects
  • Corticosteroid treatment cessation
  • Corticosteroid use in pregnancy
  • Corticosteroids interactions
  • Diabetes mellitus
  • Type 1 diabetes mellitus
  • Types of insulin
  • Type 2 diabetes mellitus
  • Treating type 2 diabetes (NICE)
  • Biguanides
  • Sulphonylureas
  • Thiazolidinediones
  • DPP-4 inhibitors
  • SGLT2 inhibitors
  • Hypothyroidism
  • Hyperthyroidism
  • Hyperthyroidism treatment
  • Osteoporosis
  • Bisphosphonates
  • Strontium ranelate
  • Hormone replacement therapy
  • Male sex hormone responsive conditions

 

The endocrine system study guide is intended to provide high-yield notes in preparation for the GPhC registration assessment. The guide has been produced in accordance with the latest British National Formulary (BNF).

 

Disclaimer: These notes are not meant to replace your lecture/study notes but are instead supplementary resources to aid in studying. While all attempts were made to ensure validity and accuracy, there is no guarantee of validity or accuracy. The purchaser of this guide assumes all responsibility for the use of this material. The author does not assume any responsibility or liability whatsoever on behalf of any purchaser or reader of these guides.

 

No refunds due to the PDF nature of these notes

    £24.99Price
    bottom of page